TY - JOUR
T1 - Erratum
T2 - Turning Toxic Nanomaterials into a Safe and Bioactive Nanocarrier for Co-delivery of DOX/pCRISPR (ACS Applied Bio Materials (2021) 4: 6 (5336−5351) DOI: 10.1021/acsabm.1c00447)
AU - Rabiee, Navid
AU - Bagherzadeh, Mojtaba
AU - Ghadiri, Amir Mohammad
AU - Fatahi, Yousef
AU - Aldhaher, Abdullah
AU - Makvandi, Pooyan
AU - Dinarvand, Rassoul
AU - Jouyandeh, Maryam
AU - Saeb, Mohammad Reza
AU - Mozafari, Masoud
AU - Shokouhimehr, Mohammadreza
AU - Hamblin, Michael R.
AU - Varma, Rajender S.
N1 - Publisher Copyright:
© 2023 American Chemical Society.
PY - 2023/3/20
Y1 - 2023/3/20
N2 - After much investigation, we realized that there is a flaw in Figure 2. One of the spectra was wrongly placed in the image (by one of the students) and should be removed. The revised (corrected) Figure 2 is below. In the Figure 2 caption, the term of “spectra” for XRD changes to “pattern”. Also, Figure 7f and Figure 10f,g are replaced with the new images as listed below. Also, in the text, the sentence “The broadening in the diffraction peaks corresponds to the presence of DOX (after incorporation) and the byproducts” should be changed to “The broadening in the diffraction peaks corresponds to the presence of leaf extracts and the byproducts.” (Figure Presented).
AB - After much investigation, we realized that there is a flaw in Figure 2. One of the spectra was wrongly placed in the image (by one of the students) and should be removed. The revised (corrected) Figure 2 is below. In the Figure 2 caption, the term of “spectra” for XRD changes to “pattern”. Also, Figure 7f and Figure 10f,g are replaced with the new images as listed below. Also, in the text, the sentence “The broadening in the diffraction peaks corresponds to the presence of DOX (after incorporation) and the byproducts” should be changed to “The broadening in the diffraction peaks corresponds to the presence of leaf extracts and the byproducts.” (Figure Presented).
UR - http://www.scopus.com/inward/record.url?scp=85149102679&partnerID=8YFLogxK
U2 - 10.1021/acsabm.2c01005
DO - 10.1021/acsabm.2c01005
M3 - Comment/debate
C2 - 36786808
AN - SCOPUS:85149102679
SN - 2576-6422
VL - 6
SP - 1313
EP - 1314
JO - ACS Applied Bio Materials
JF - ACS Applied Bio Materials
IS - 3
ER -